| Laura A George, CRNA | |
|
333 Route 25a Ste 225, Rocky Point, NY 11778-8802 | |
| (631) 744-0396 | |
| Not Available |
| Full Name | Laura A George |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 21 Years |
| Location | 333 Route 25a Ste 225, Rocky Point, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457374670 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 407611 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John T Mather Memorial Hospital Of Port Jefferson | Port jefferson, NY | Hospital |
| St Charles Hospital | Port jefferson, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
| Long Island Anesthesia Physicians Llp | 7113825381 | 136 |
News Archive
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
Close to 100 different Southern California law enforcement agencies will go head-to-head in the spirit of friendly competition to see which agency can donate the most blood through the American Red Cross in the 4th Annual Battle of the Badges blood drives.
Researchers from Boston University School of Medicine in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer. The findings, which appear in the April 7th issue of Science Translational Medicine, will allow the researchers to use a genomic approach to prevent lung cancer in these individuals and to personalize cancer chemoprophylaxis and therapy.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
A survey of patients admitted to Massachusetts General Hospital (MGH) has found that patients reporting greater levels of satisfaction with their care and good communication with the health care providers were significantly less like to readmitted to the hospital in the 30 days after discharge.
› Verified 6 days ago
| Entity Name | Long Island Anesthesia Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952387276 PECOS PAC ID: 7113825381 Enrollment ID: O20040106000103 |
News Archive
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
Close to 100 different Southern California law enforcement agencies will go head-to-head in the spirit of friendly competition to see which agency can donate the most blood through the American Red Cross in the 4th Annual Battle of the Badges blood drives.
Researchers from Boston University School of Medicine in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer. The findings, which appear in the April 7th issue of Science Translational Medicine, will allow the researchers to use a genomic approach to prevent lung cancer in these individuals and to personalize cancer chemoprophylaxis and therapy.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
A survey of patients admitted to Massachusetts General Hospital (MGH) has found that patients reporting greater levels of satisfaction with their care and good communication with the health care providers were significantly less like to readmitted to the hospital in the 30 days after discharge.
› Verified 6 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851456701 PECOS PAC ID: 1355232422 Enrollment ID: O20040329001569 |
News Archive
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
Close to 100 different Southern California law enforcement agencies will go head-to-head in the spirit of friendly competition to see which agency can donate the most blood through the American Red Cross in the 4th Annual Battle of the Badges blood drives.
Researchers from Boston University School of Medicine in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer. The findings, which appear in the April 7th issue of Science Translational Medicine, will allow the researchers to use a genomic approach to prevent lung cancer in these individuals and to personalize cancer chemoprophylaxis and therapy.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
A survey of patients admitted to Massachusetts General Hospital (MGH) has found that patients reporting greater levels of satisfaction with their care and good communication with the health care providers were significantly less like to readmitted to the hospital in the 30 days after discharge.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura A George, CRNA 333 Route 25a Ste 225, Rocky Point, NY 11778-8802 Ph: (631) 744-0396 | Laura A George, CRNA 333 Route 25a Ste 225, Rocky Point, NY 11778-8802 Ph: (631) 744-0396 |
News Archive
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
Close to 100 different Southern California law enforcement agencies will go head-to-head in the spirit of friendly competition to see which agency can donate the most blood through the American Red Cross in the 4th Annual Battle of the Badges blood drives.
Researchers from Boston University School of Medicine in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer. The findings, which appear in the April 7th issue of Science Translational Medicine, will allow the researchers to use a genomic approach to prevent lung cancer in these individuals and to personalize cancer chemoprophylaxis and therapy.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
A survey of patients admitted to Massachusetts General Hospital (MGH) has found that patients reporting greater levels of satisfaction with their care and good communication with the health care providers were significantly less like to readmitted to the hospital in the 30 days after discharge.
› Verified 6 days ago
Kaitlyn Margaret Bonser, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a Ste 225, Rocky Point, NY 11778 Phone: 631-503-1400 | |
Leonard A Goldberg, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a Ste 225, Rocky Point, NY 11778 Phone: 631-744-0396 | |
Michael V Lampasona, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a, Suite 225, Rocky Point, NY 11778 Phone: 631-744-3671 Fax: 631-744-6205 | |
Colleen Erbis, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 333 Route 25a, Rocky Point, NY 11778 Phone: 631-744-3671 Fax: 631-744-6205 | |
Alison M Maletta, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a Ste 225, Rocky Point, NY 11778 Phone: 631-744-0396 | |
Donna M Defilippi, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a Ste 225, Rocky Point, NY 11778 Phone: 631-744-0396 |